
Biopharma Startup Relocates to BLT’s Stamford MXU
Biopharma firm SpringWorks Therapeutics has signed a 23,919-square-foot lease to relocate its company headquarters from New York City to 2 Harbor Point Square in Stamford, CT. The property is part of Harbor Point, the 120-acre mixed-use waterfront community in Stamford’s South End, developed by Building & Land Technology.
CBRE’s John Isaacs and Colin Reilly represented SpringWorks in the deal, which involved assigning the lease of the existing tenant, Structured Portfolio Group, to SpringWorks.
Torey Walsh of NKF represented Structured Portfolio, while BLT was represented internally by Leslie Whatley and Jim Phillips.
“SpringWorks Therapeutics is a growing biopharmaceutical company with an exceptional leadership team that has deep experience in drug development for patients with severe rare diseases and cancers,” said Isaacs. “Harbor Point, a multi-phased, mixed-use development overlooking Stamford Harbor, continues to grow as a destination for corporate tenants, retailers and residents, and was the perfect fit for SpringWorks’ new headquarters.”
For comments, questions or concerns, please contact Paul Bubny
- ◦Lease